EDGAR Filing Documents for 0000950123-05-008871

Form 8-K - Current report:

SEC Accession No. 0000950123-05-008871

Filing Date

2005-07-25

Accepted

2005-07-25 15:22:30

Documents

Period of Report

2005-07-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	y11062e8vk.htm	8-K	23130
2	EX-3.1: RESTATED CERTIFICATE OF INCORPORATION	y11062exv3w1.txt	EX-3.1	23481
3	EX-10.1: RESTRICTED STOCK GRANT AGREEMENT	y11062exv10w1.txt	EX-10.1	12744
4	EX-10.2: INCENTIVE STOCK OPTION GRANT AGREEMENT	y11062exv10w2.txt	EX-10.2	15334
5	EX-10.3: NON-QUALIFIED STOCK OPTION GRANT AGREEMENT	y11062exv10w3.txt	EX-10.3	13971
6	EX-10.4: AMENDMENT NO. 1 TO 2004 STOCK INCENTIVE PLAN	y11062exv10w4.txt	EX-10.4	1692
7	EX-99.1: PRESS RELEASE	y11062exv99w1.txt	EX-99.1	8735
	Complete submission text file	0000950123-05-008871.txt		100726

Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98021

Business Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600

NASTECH PHARMACEUTICAL CO INC (Filer) CIK: 0000737207 (see all company filings)